Your browser doesn't support javascript.
loading
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.
Levin, Myron J; Huang, Sharon; Moscicki, Anna-Barbara; Song, Lin-Ye; Read, Jennifer S; Meyer, William A; Saah, Alfred J; Richardson, Kelly; Weinberg, Adriana.
Afiliación
  • Levin MJ; Section of Pediatric Infectious Diseases, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States. Electronic address: myron.levin@ucdenver.edu.
  • Huang S; Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA 02115, United States.
  • Moscicki AB; Department of Pediatrics, University of California Los Angeles, Los Angeles, CA 19954, United States.
  • Song LY; Formerly Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA 02115, United States; Office of Science, Food & Drug Administration; Silver Spring, MD 20993, United States.
  • Read JS; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, United States.
  • Meyer WA; Quest Diagnostics, Baltimore, MD, United States.
  • Saah AJ; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Richardson K; Section of Pediatric Infectious Diseases, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
  • Weinberg A; Section of Pediatric Infectious Diseases, Departments of Pediatrics, Medicine, and Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
Vaccine ; 35(13): 1712-1720, 2017 03 23.
Article en En | MEDLINE | ID: mdl-28238631

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Inmunización Secundaria / Infecciones por Papillomavirus / Vacuna Tetravalente Recombinante contra el Virus del Papiloma Humano Tipos 6, 11 , 16, 18 / Anticuerpos Antivirales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Male Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Inmunización Secundaria / Infecciones por Papillomavirus / Vacuna Tetravalente Recombinante contra el Virus del Papiloma Humano Tipos 6, 11 , 16, 18 / Anticuerpos Antivirales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Male Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article